Functional Characterization of the Human BRCA1 ∆11 Splicing Isoforms in Yeast

Area of Science:

• Genetics
• Molecular Biology
• Cancer Research

Background:

• BRCA1 is a critical tumor suppressor gene with multiple naturally occurring splicing isoforms, such as Δ9-11, Δ11, and Δ11q, which lack exon 11.
• These isoforms exhibit altered protein activity compared to full-length BRCA1 and are found in both normal and cancerous cells.
• Germline intronic variants can lead to the exclusive expression of these Δ11 isoforms, but their impact on cancer risk is currently uncertain, classifying them as variants of uncertain significance (VUS).

Purpose of the Study:

• To evaluate the functional activity of BRCA1 Δ11 splicing isoforms.
• To determine if the exclusive expression of these isoforms contributes to increased cancer risk.
• To improve the classification of BRCA1 variants of uncertain significance (VUS) by elucidating the pathogenic potential of splicing isoforms.

Main Methods:

• Utilized a validated yeast-based functional assay, previously employed for missense BRCA1 variants.
• Compared the functional activity of Δ11 splicing isoforms against known pathogenic missense BRCA1 variants.
• Assessed the functional implications of exclusive expression of BRCA1 Δ11 isoforms.

Main Results:

• The study provides a functional assessment of BRCA1 Δ11 splicing isoforms using a yeast assay.
• Comparative analysis was performed between these isoforms and established pathogenic missense variants.
• Insights into the functional consequences of specific BRCA1 splicing patterns were generated.

Conclusions:

• The functional assay offers a method to evaluate the pathogenic potential of BRCA1 splicing isoforms.
• This research aims to clarify the cancer risk associated with intronic variants leading to exclusive Δ11 isoform expression.
• Improved classification of BRCA1 VUS may be achievable through understanding the functional impact of these isoforms.